Boost For Minor Ailment Treatment

Running a national minor ailment scheme through community pharmacy is cost effective, and clinically effective, new research claims.

Researchers from the University of Technology Sydney conducted a randomised controlled trial in over 700 patients from 30 Western Sydney pharmacies to compare the clinical impact of a community pharmacist delivered minor ailment service (MAS) compared with usual pharmacist care.

An economic analysis of the research has now found that, on average, “MAS was more costly but also more effective (in terms of symptom resolution and quality adjusted life year gains) compared to usual care,” they found.

Their study, and previous research had “proven clinical effectiveness” of minor ailment schemes when compared to current usual practice in Australian community pharmacies, the authors said.

Click here to read more. See the Elastoplast Wound Care module below for more information on wound care.

Source: https://ajp.com.au/news/boost-for-minor-ailment-treatment/, viewed 10 August 2020.